New member of the RedVLP consortium: Ikosaedrika Biologicals S.L.

Ikosaedrika Biologicals S.L. is the new enterprise emerged from RedVLP consortium, and was  launched  as a spin-off of the University of the Basque Country (EHU). This enterprise will be focused on the development of human vaccines based on VLPs. One of the Ikosaedrika’s targets is a therapeutic vaccine against Chagas, a project in which is also involved Marcelo Silva, from the UFRN, in Natal, Brazil. 
http://ikosaedrika.com/

2020-12-08T10:00:39-03:00 October 30th, 2020|Sin categoría|